Prognostic factors for survival in patients with metastatic melanoma treated with ipilimumab: Turkish Oncology Group (TOG) Study


Urun Y., Abali H., Turna H., Esin E., Sedef A. M., Alkan A., ...More

European Cancer Congress, Vienna, Austria, 01 January 2015, vol.51, (Summary Text) identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 51
  • Doi Number: 10.1016/s0959-8049(16)31872-x
  • City: Vienna
  • Country: Austria
  • Hacettepe University Affiliated: Yes